Contributing Factors for Low Birth Weight among Newborns in a Maternity Hospital, Kathmandu
Abstract
Background: Low birth weight (LBW) is a major determinant of neonatal morbidity and mortality in developing countries. Its causes are multifactorial and not yet fully understood. Early identification and management of maternal and environmental risk factors can help reduce the incidence and consequences of LBW. This study aimed to identify contributing factors of LBW among newborns delivered at a tertiary maternity hospital in Nepal.
Methods: A case-control study was conducted at Paropakar Maternity and Women’s Hospital, Kathmandu, among 129 postnatal mothers (43 cases and 86 controls) selected using a consecutive sampling for cases and simple random sampling for control. Data were collected through in-person interviews using a validated structured questionnaire and antenatal chart review. Data were analyzed using descriptive and inferential statistics, and a p-value <0.05 was considered statistically significant.
Results: The LBW was associated with included short birth interval (<24 months) (p 0.044), severe nausea and vomiting (p 0.002), non-consumption of folic acid (p 0.027), non-consumption of calcium supplements (p 0.027), consumption of tobacco (p 0.006) and exposure to active or passive smoking (p 0.004). Preterm birth and inadequate daytime rest had strong association with LBW (p values <0.001)
Conclusions: Preterm birth and inadequate daytime rest are the strong contributors for LBW. These findings highlight the importance of timely and comprehensive prenatal…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.